PROM1 and laryngotracheoesophageal cleft: To characterize circulating CD133+ cells in HCC patients, Zekri et al. [117] analyzed the expression of 13 miRNAs in purified CD133-positive cells separated from the peripheral blood of healthy volunteers and from patients with HCV-related chronic liver diseases (CHC), cirrhosis (LC), and HCC.